Literature DB >> 23517197

Prognostic significance of the worst grade in hepatocellular carcinoma with heterogeneous histologic grades of differentiation.

Dai Hoon Han1, Gi Hong Choi, Kyung Sik Kim, Jin Sub Choi, Young Nyun Park, Seung Up Kim, Jun Yong Park, Sang Hoon Ahn, Kwang-Hyub Han.   

Abstract

BACKGROUND AND AIM: Although tumor differentiation is a known prognostic factor after the treatment of hepatocellular carcinoma (HCC), there have not been any studies on the prognostic significance of tumor differentiation in HCC with heterogeneous histologic grades. In this study, we attempted to ascertain whether the major or the worst grade in mixed histologic type HCC determines the prognosis after liver resection.
METHODS: From January 1996 to March 2010, a total of 724 patients underwent curative resection of HCC at Yonsei University Health System, Korea. Of those, we excluded 99 patients who had total necrosis because of previous treatment. Among the remaining 625 patients, we compared the homogeneous moderately differentiated group (HG2, n = 241), mixed histologic grades with the worst component as poorly differentiated group (M2, n = 142), and homogeneous poorly differentiated group (HG3, n = 156). The clinicopathologic features, disease-free survival (DFS) and overall survival (OS) in each group were analyzed.
RESULTS: The DFS and OS were significantly lower in M2 than in HG2 (P = 0.004 and 0.025, respectively) whereas those of M2 were not significantly different from HG3. There were no significant differences in the clinicopathologic features of each group except that microvascular invasion was more frequently observed in M2 than in HG2. On multivariate analysis, being in the worst histologic group (M2 and HG3) was an independent poor prognostic factor for DFS and OS (P = 0.028 and < 0.001, respectively).
CONCLUSIONS: In patients with advanced histologic grade, the worst histologic grade may determine the prognosis after curative resection of HCC.
© 2013 Journal of Gastroenterology and Hepatology Foundation and Wiley Publishing Asia Pty Ltd.

Entities:  

Keywords:  carcinoma; hepatectomy; hepatocellular; neoplasm grading

Mesh:

Year:  2013        PMID: 23517197     DOI: 10.1111/jgh.12200

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  23 in total

1.  Molecular alterations in the carcinogenesis and progression of hepatocellular carcinoma: Tumor factors and background liver factors.

Authors:  Yoshikuni Inokawa; Kenichi Inaoka; Fuminori Sonohara; Masamichi Hayashi; Mitsuro Kanda; Shuji Nomoto
Journal:  Oncol Lett       Date:  2016-09-15       Impact factor: 2.967

2.  Preoperative and postoperative nomograms for predicting early recurrence of hepatocellular carcinoma without macrovascular invasion after curative resection.

Authors:  Yanfang Zhang; Xuezhong Lei; Liangliang Xu; Xiaoju Lv; Mingqing Xu; Hong Tang
Journal:  BMC Surg       Date:  2022-06-17       Impact factor: 2.030

3.  Immunohistochemistry panel segregates molecular types of hepatocellular carcinoma in Brazilian autopsy cases.

Authors:  Aloísio Felipe-Silva; Alda Wakamatsu; Cinthya Dos Santos Cirqueira; Venâncio Avancini Ferreira Alves
Journal:  World J Gastroenterol       Date:  2016-07-21       Impact factor: 5.742

4.  Exosome-related lncRNAs as predictors of HCC patient survival: a prognostic model.

Authors:  Yuchen Hou; Zheng Yu; Nga Lei Tam; Shanzhou Huang; Chengjun Sun; Rongchang Wang; Xuzhi Zhang; Zekang Wang; Yi Ma; Xiaoshun He; Linwei Wu
Journal:  Am J Transl Res       Date:  2018-06-15       Impact factor: 4.060

5.  In hepatocellular carcinomas, any proportion of poorly differentiated components is associated with poor prognosis after hepatectomy.

Authors:  Kazunari Sasaki; Masamichi Matsuda; Yu Ohkura; Yusuke Kawamura; Masafumi Inoue; Masaji Hashimoto; Kenji Ikeda; Hiromitsu Kumada; Goro Watanabe
Journal:  World J Surg       Date:  2014-05       Impact factor: 3.352

6.  Impact of Postoperative Complications on Long-Term Survival After Resection of Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis.

Authors:  Junjie Kong; Guangbing Li; Jiawei Chai; Guangsheng Yu; Yong Liu; Jun Liu
Journal:  Ann Surg Oncol       Date:  2021-06-23       Impact factor: 5.344

7.  Preferential targeting of disseminated liver tumors using a recombinant adeno-associated viral vector.

Authors:  Marco Della Peruta; Adam Badar; Cecilia Rosales; Shilpa Chokshi; Azadeh Kia; Devhrut Nathwani; Eva Galante; Ran Yan; Erik Arstad; Andrew M Davidoff; Roger Williams; Mark F Lythgoe; Amit C Nathwani
Journal:  Hum Gene Ther       Date:  2015-02       Impact factor: 5.695

Review 8.  Hepatocellular carcinoma: making sense of morphological heterogeneity, growth patterns, and subtypes.

Authors:  Michael S Torbenson
Journal:  Hum Pathol       Date:  2020-12-30       Impact factor: 3.526

Review 9.  Hepatocellular carcinoma: a clinical and pathological overview.

Authors:  Salvatore Lorenzo Renne; Samantha Sarcognato; Diana Sacchi; Maria Guido; Massimo Roncalli; Luigi Terracciano; Luca Di Tommaso
Journal:  Pathologica       Date:  2021-06

10.  Prognostic value of the ALBI grade among patients with single hepatocellular carcinoma without macrovascular invasion.

Authors:  Wenhao Chen; Zijian Zhang; Xianrui Fang; Li Xiong; Yu Wen; Jiangjiao Zhou; Fanhua Kong; Heng Zou
Journal:  Medicine (Baltimore)       Date:  2021-06-18       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.